US › Healthcare

Inogen Inc (INGN)

US · Healthcare · Medical Devices

$6.92+3.13%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$85.1M
Revenue YoY
+3.4%
Net profit
$-8.3M
Profit YoY
-34.8%
EPS
$-0.14
EPS estimate
$-0.21
Net margin
-9.8%

EPS came in at -0.14 against a street estimate of -0.21 — a beat of 33.3%.

Key statistics

Market cap
$174.6M
Forward P/E
0.0
P/B
0.95
Book value
$6.68
EPS (TTM)
$-0.91
52-week high
$9.13
52-week low
$5.34
50-day MA
$6.46
200-day MA
$6.67
Beta
1.59

Analyst view

Analysts rate Inogen Inc a buy (2 buy, 0 hold, 1 sell out of 3) with an average price target of $12.67.

Shareholding

Insiders
12.64%
Institutions
77.48%

Largest institutional holders

FundStake
BlackRock Inc6.08%
Vanguard Group Inc5.25%
Armistice Capital, LLC4.43%
Acadian Asset Management LLC4.00%
Vanguard Capital Management, LLC3.83%
Ameriprise Financial Inc3.17%
Dafna Capital Management LLC3.12%
Point72 Asset Management, L.P.2.37%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Inogen Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.